Biocryst Pharmaceuticals (BCRX) EV to EBIT (2025)
Biocryst Pharmaceuticals' (BCRX) EV to EBIT stood at 4.07 in Q4 2025, down 77.6% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) EV to EBIT (2025) Analysis & Trends
Starting with Q1 2025, Biocryst Pharmaceuticals' EV to EBIT history includes 4 quarters.
- Per Business Quant, the preceding three quarters came in at 18.20 (Q3 2025), 29.90 (Q2 2025) and 38.40 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Biocryst Pharmaceuticals | 2.02 Bn | 940.71 Mn | 214.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4.07 |
| Sep 30, 2025 | 18.20 |
| Jun 30, 2025 | 29.90 |
| Mar 31, 2025 | 38.40 |
API Access
Biocryst Pharmaceuticals EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();